The IVS-II-1 (G → A) β0-thalassemia mutation in CIS with HbA2-troodos [δ116(G18)Arg → Cys (CGC →TGC)] causes a complex prenatal diagnosis in an Iranian family

Hemoglobin

Volumn 29, Issue 4, 2005, Pages 289-292

  Eram, S Mohammad ^a   Azimifar, Babak ^a   Abolghasemi, Hassan ^b   Foulady, Panty ^a   Lotfi, Vida ^a   Masrouri, Maryam ^a   Hosseini, Maesomeh ^a   Abdolhosseini, Afsaneh ^a   Zeinali, Sirous ^a,c  

^a Medical Genetics Laboratory of Dr Zeinali   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

mutation; Hb A2 Troodos; Iran; Thalassemia (thal)

Indexed keywords

HEMOGLOBIN A2;

ADULT; ARTICLE; BETA THALASSEMIA; CASE REPORT; FEMALE; GENE MUTATION; HUMAN; MALE; PHENOTYPE; PRENATAL DIAGNOSIS;

ADULT; BETA-THALASSEMIA; ERYTHROCYTE INDICES; FAMILY HEALTH; FEMALE; HEMOGLOBIN A2; HEMOGLOBINS, ABNORMAL; HUMANS; IRAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 28844471415     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260500310828     Document Type: Article

References (11)

1. Weatherall DJ, Clegg JB. Hereditary persistence of fetal hemoglobin. In: Gibbons R, Higgs DR, Olivieri NF, Wood WF, Eds. The Thalassaemia Syndromes. 4th ed. Oxford: Blackwell Scientific Publishers, 2001:450-455.
2. Weatherall DJ. The thalassemia. In: Stamatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus HE, Eds. The Molecular Basis of Blood Diseases. 4th ed. Philadelphia: WB Saunders Company, 2001:135-182.
3. Pirastu M, Ristaldi MS, Loudianos G, Murru S, Sciarratta GV, Parodi MI, Leone D, Agosti S, Cao A. Molecular analysis of atypical β-thalassemia heterozygotes. Ann NY Acad Sci 1990; 612:90-97.
4. Trifillis P, Ioannou P, Schwartz E, Surrey S. Identification of four novel δ-globin gene mutations in Greek Cypriots using polymerase chain reaction and automated fluorescence-based DNA sequence analysis. Blood 1991; 78(12):3298-3305.
5. Samavat A, Modell B. Iranian national thalassaemia screening program. BMJ 2004; 329(7475):1134-1137.
6. Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of β-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet 1990; 33(8719):834-837.
7. 2 (type 2) β-thalassemia in Greece. Hematol Pathol 1994; 8(1-2):25-34.
8. De Angioletti M, Lacerra G, Gaudiano C, Mastrolonardo G, Pagano L, Mastrullo L, Masciandaro S, Carestia C. Epidemiology of the δ globin alleles in southern Italy shows complex molecular, genetic, and phenotypic features. Hum Mutat 2002; 20(5):358-367.
9. Gγ - 158 C→T mutation on the Hb F level. Am J Hematol 2000; 64(3):151-155.
10. Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC. Response to hydroxyurea treatment in Iranian transfusion-dependent β-thalassemia patients. Haematologica 2004; 89(10):1172-1178.
11. Karimi M, Yarmohammadi H, Farjadian S, Zeinali S, Moghaddam Z, Cappellini MD, Giordano PC. β-Thalassemia intermedia from southern Iran: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002; 26(2):147-154.